CClinicalTrials.gg
CompletedNCT02547272DigeSTAPHUpdated Mar 23, 2016

Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus

An observational study in Staphylococcus Aureus, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-03-23.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

Nasal colonization with S. aureus is a risk factor for infection with this bacterium. A methodologically well conducted study of S. aureus bacteremia showed that 80% of S. aureus bacteremia with are due to the strain isolated in the nasal level. However, as part of a study coordinated by the CHU of Saint-Etienne, less than 50% of infections in prosthetic orthopedic devices have been linked to nasal carriage . Outside of exogenous infections, intestinal colonization with S. aureus could be an alternative source of endogenous infections with the waning of orthopedic surgery. In the general population, considering that about one third of the subjects were colonized with S. aureus nasal level and 1 in 5 in the intestine However the proportion of exclusive intestinal porting is not well known .

This study will analyze, among ICU patients, porting S. aureus nasal and rectal level. It will better clarify the relationship between nasal and rectal ports and the risk of developing an infection.

Read the detailed description

The adult patients hospitalized in intensive care at the University Hospital of Saint-Etienne have a multiresistant bacteria porting screening at the nose and rectum at admission and then once a week. These samples will be carried unchanged way for the study but will also be a research S Aureus

02

Conditions studied

  • Staphylococcus Aureus

Keywords

  • Intensive care
  • S Aureus
03

In context

Staphylococcal Infections

273 studies on the registry are indexed under Staphylococcal Infections; 29 are open to participants now.

This study's enrollment of 400 is above the median of 200 across 81 observational studies indexed under Staphylococcal Infections.

Browse Staphylococcal Infections studies →

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 578 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients hospitalized in intensive care

Inclusion criteria

  • patients hospitalized in intensive care and benefiting from a screening multiresistant bacteria in nasal and rectal level under routine care

Exclusion criteria

Exclusion Criteria:

  • refusal of the patient's family
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Nasal and rectal samples

    ICU patients with nasal and rectal bacterial samples for the presence of S Aureus

    Procedure: Nasal and rectal bacterial samples

Interventions

  • ProcedureNasal and rectal bacterial samples

    Bacterial nasal and rectal samples at admission and one weekly for the presence of S Aureus

06

What researchers measure

Primary outcomes

  1. prevalence of S. aureus colonization at rectal level

    The presence of a colony of S. aureus on one of the samples

    Time frame: 1 month

Secondary outcomes

  1. S. aureus strains similar to nasal and rectal level

    S. aureus strains similar in molecular typing

    Time frame: 1 month

07

Study locations

1 site
  • CHU de Saint-Etienne
    St Etienne, 42000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02547272
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Responsible party
Sponsor
First posted
Sep 11, 2015
Start date
Feb 2013
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Mar 23, 2016

Study contacts

Philippe BERTHELOT, Md-PhD
principal investigator · CHU SAINT-ETIENNE

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion